US2019167165A1PendingUtilityA1
Analyte Monitoring Device and Methods of Use
Est. expiryNov 1, 2025(expired)· nominal 20-yr term from priority
A61B 5/1477A61B 2562/125A61B 5/742A61B 5/4848A61B 2017/3409A61B 5/4839A61B 2562/085G01N 27/3272A61B 5/746A61B 2560/0209A61B 5/0031A61B 5/7246A61B 2562/0271A61B 5/7445A61B 5/14865A61B 5/7455G01N 27/3273A61B 5/7275A61B 5/14532A61B 2560/0475A61B 5/7405A61B 5/14542A61B 5/7278A61B 2017/3407A61B 5/1495A61B 5/1473A61B 5/1451A61B 2562/0295A61B 5/7282A61B 5/14546A61B 17/3468
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
In aspects of the present disclosure, a no coding blood glucose monitoring unit including a calibration unit is integrated with one or more components of an analyte monitoring system to provide compatibility with in vitro test strip that do not require a calibration code is provided. Also disclosed are methods, systems, devices and kits for providing the same.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method, comprising:
receiving an analyte sensor at an analyte sensor interface; determining, using one or more processors, a type of the analyte sensor; recognizing, using the one or more processors, the type of the analyte sensor without a user input as a no-coding analyte sensor; and determining, using the one or more processors, an analyte level based on one or more signals generated by the analyte sensor and a universal calibration parameter that is associated with analyte sensors that are no-coding analyte sensors.
2 . The method of claim 1 , further including wirelessly receiving an analyte related data from an in vivo analyte sensor in fluid contact with a bodily fluid.
3 . The method of claim 2 , further including determining an analyte level in the bodily fluid in real time based on the received analyte related data.
4 . The method of claim 3 , wherein the bodily fluid includes dermal fluid.
5 . The method of claim 3 , wherein the bodily fluid includes interstitial fluid.
6 . The method of claim 3 , wherein the analyte level is related to one or more of a glucose level, lactate level, or oxygen level.
7 . The method of claim 3 , wherein the analyte sensor includes a plurality of electrodes including a working electrode comprising an analyte-responsive enzyme.
8 . The method of claim 7 , wherein the enzyme is bound to a polymer disposed on the working electrode.
9 . The method of claim 7 , wherein the working electrode comprises a mediator.
10 . The method of claim 9 , wherein the mediator is bound to a polymer disposed on the working electrode.
11 . The method of claim 9 , wherein the mediator is crosslinked with a polymer disposed on the working electrode.
12 . The method of claim 3 , wherein the analyte sensor includes a plurality of electrodes including a working electrode comprising a mediator.
13 . The method of claim 12 , wherein the mediator is bound to a polymer disposed on the working electrode.
14 . The method of claim 12 , wherein the mediator is crosslinked with a polymer disposed on the working electrode.
15 . A method, comprising:
identifying, using one or more processors, an analyte sensor received at an analyte sensor interface of a display device without a user input as a no-coding analyte sensor; determining, using the one or more processors, an analyte level based on one or more signals generated by the analyte sensor and a universal calibration parameter that is associated with analyte sensors that are no-coding analyte sensors; and outputting the determined analyte level at an output unit operatively coupled to the one or more processors.
16 . The method of claim 15 , further including wirelessly receiving an analyte related data from an in vivo analyte sensor in fluid contact with a bodily fluid.
17 . The method of claim 16 , further including determining an analyte level in the bodily fluid in real time based on the received analyte related data.
18 . The method of claim 17 , wherein the bodily fluid includes dermal fluid.
19 . The method of claim 17 , wherein the bodily fluid includes interstitial fluid.
20 . The method of claim 17 , wherein the analyte level is related to one or more of a glucose level, lactate level, or oxygen level.Join the waitlist — get patent alerts
Track US2019167165A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.